Riskpilot← Back to searchSign inGet full accessADVITA AB
ABActiveOrg 5567842108Kungsgatan 29 5trMedical specialists activities · NACE 8622Est. 20092 employees
Revenue 2025
SEK 5M
+156% vs 2024
EBITDA margin
28.5%
+18% vs 2024
Equity ratio
74.1%
Financial strength
Net profit 2025
SEK 1,1M
+17% vs 2024
| Revenue | SEK 5M | +156% |
| EBITDA | SEK 1,4M | +18% |
| Net profit | SEK 1,1M | +17% |
| Total assets | SEK 1,7M | +40% |
| Equity | SEK 1,2M | +15% |
| Employees | 2 | — |
Legal name
ADVITA AB
Org number
5567842108
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
18 juni 2009
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva sjukvårdsverksamhet samt därmed förenlig verksamhet.
Address
Kungsgatan 29 5tr
Email
advitaplastik@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 876 | 4 057 | 4 126 | 1 964 | 5 025 |
| Staff expenses | — | — | −754 | — | −1 961 |
| EBITDA | 2 520 | 2 569 | 2 390 | 1 215 | 1 431 |
| Depreciation & amort. | −12 | −12 | −12 | −12 | — |
| EBIT | 2 508 | 2 557 | 2 377 | 1 203 | 1 431 |
| Net financials | −3 | −2 | −2 | 13 | −2 |
| Profit before tax | 1 876 | 1 908 | 17 | 1 216 | 1 429 |
| Tax | −393 | −400 | −42 | −250 | −298 |
| Net profit | 1 483 | 1 508 | −25 | 966 | 1 131 |
| Item | 2022 | 2023 | 2024 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 869 | 4 653 | 1 689 | 1 186 | 1 661 |
| Equity | 1 618 | 1 625 | 100 | 1 067 | 1 231 |
| Long-term debt | 0 | 0 | — | 0 | — |
| Short-term debt | 269 | 398 | 1 588 | 119 | 430 |
| Total debt | 269 | 398 | 1 588 | 119 | 430 |
EBITDA margin
28.5%
This company
15.8%
Market median
+80% vs market
20222025
Equity ratio
74.1%
This company
38.2%
Market median
+94% vs market
20222025
Return on equity
91.9%
This company
18.4%
Market median
+399% vs market
20222025
Net profit margin
22.5%
This company
8.1%
Market median
+178% vs market
20222025
Asset turnover
3.02×
This company
1.12×
Market median
+170% vs market
20222025
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-11-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-05-01 – 2024-10-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2024 | |
| Board of Directors | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Mundus Medical AB
ADVITA AB Board members of ADVITA AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Martin Olof Axel Löfgren | Deputy Board Member | 0 companies |
| Ebba Christina Blomqvist | Deputy Board Member | 0 companies |
| Petra Brita Maria Peterson | Board of Directors | 0 companies |
| Karl Lennart Blomqvist | Board of Directors | 0 companies |